{"rewrite":{"id":"r_3028be53b94865612b214294","clusterId":"c_f55b9041d6960193289a2067","slug":"university-of-tokyo-ai-startup-partners-with-shionogi-on-drug-development","model":"deepseek-v4-flash","headline":"University of Tokyo AI Startup Partners With Shionogi on Drug Development","summary":"OptimAIze Consulting, an AI startup from the University of Tokyo Faculty of Medicine, has signed a consulting contract with pharmaceutical company Shionogi to support drug development using AI and real-world data. The partnership aims to select target diseases and integrate clinical and non-clinical data to improve the probability of success in clinical development.","whyItMatters":"A specialized AI team from academia and a major drugmaker are formalizing a collaboration to apply machine learning and large-scale medical data to the drug discovery process, targeting the industry's long-standing efficiency problem.","webCardHtml":"\u003cp\u003eThe contract, finalized in June 2026, covers consulting services that will use large-scale medical databases and advanced AI analysis techniques including machine learning and network analysis. The work is designed to improve decision-making and expand the options available during drug development. OptimAIze Consulting was founded by researchers from the University of Tokyo Faculty of Medicine and employs engineers with medical qualifications who perform analysis themselves. Shionogi, a research-driven pharmaceutical company founded in 1878, has been shifting toward a Healthcare as a Service model and was named a DX Brand by Japan\u0026#39;s Ministry of Economy, Trade and Industry for 2026.\u003c/p\u003e","blueskyPost":"OptimAIze Consulting's deal with Shionogi is a consulting contract, not a joint venture. That structure lets the startup sell methodology without taking on drug development risk itself.","twitterPost":"OptimAIze Consulting's consulting pact with Shionogi keeps the startup at arm's length from development risk while selling its AI methodology.","threadsPost":"OptimAIze Consulting's partnership with Shionogi is structured as a consulting contract. That means the startup provides methodology and analysis but avoids the financial risk of drug development itself. The deal focuses on integrating real-world data to improve clinical trial success probability.","newsletterBlurb":"OptimAIze Consulting, a University of Tokyo Faculty of Medicine spinout, has struck a consulting deal with Shionogi. The partnership will apply machine learning and network analysis to large-scale medical databases, aiming to improve the probability of success in clinical development. Shionogi, a 19th-century pharmaceutical firm, is currently pursuing a digital transformation under the Healthcare as a Service model.","attributionJson":"[{\"source\":\"ASCII.jp\",\"url\":\"https://ascii.jp/elem/000/004/416/4416831/?rss\",\"title\":\"University of Tokyo Faculty of Medicine-born AI startup OptimAIze Consulting and Shionogi \\u0026 Co., Ltd. conclude comprehensive agreement on AI × RWD utilization in drug development\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":4141,"outputTokens":1068,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1783395883,"createdAt":"2026-07-07T03:41:44.000Z","publishedAt":"2026-07-07T03:43:32.000Z","updatedAt":"2026-07-07T03:41:44.000Z"},"cluster":{"id":"c_f55b9041d6960193289a2067","canonicalTitle":"東大医学部発AIスタートアップOptimAIze Consultingと塩野義製薬、医薬品開発におけるAI ×RWD活用に関する包括契約を締結","representativeArticleId":"a_a79d4570bd8cd2ce99461417","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[],\"studios\":[],\"people\":[],\"type\":\"business\",\"domain\":\"other\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-07-07T01:30:00.000Z","lastSeenAt":"2026-07-07T01:30:00.000Z","updatedAt":"2026-07-07T03:43:33.000Z"},"attribution":[{"source":"ASCII.jp","url":"https://ascii.jp/elem/000/004/416/4416831/?rss","title":"東大医学部発AIスタートアップOptimAIze Consultingと塩野義製薬、医薬品開発におけるAI ×RWD活用に関する包括契約を締結"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":[],"studios":[],"people":[],"type":"business","domain":"other","is_roundup":false},"keyFacts":null}